Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q1 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, ₹ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
RDY:US | Dr. Reddy's Laboratories Ltd. | Depositary receipt | - | US2561352038 | $73.48 |
Company name | Dr. Reddy's Laboratories |
---|---|
Tags | #pharmacy |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | 8-2-337, ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 91 40 49002900 |
Mailing address | 8-2-337, ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 |
Website | www.drreddys.com |